The Vanguard Group 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-10 1:14 pm Purchase | 2024-06-28 | 13G | Krystal Biotech, Inc. KRYS | The Vanguard Group | 2,869,136 10.050% | 433,362 (+17.79%) | Filing |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | Krystal Biotech, Inc. KRYS | The Vanguard Group | 2,435,774 8.640% | 2,435,774 (New Position) | Filing |